Hanan Goldberg

23PUBLICATIONS
40CO-AUTHORS
Predictive and prognostic markersSolid tumoursHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Medical biotechnology diagnostics (incl. biosensors)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Jun 30, 2026
Association of Cumulative Proton Pump Inhibitor Use with Prostate Cancer Risk and Outcomes: A Population-Based Cohort Study.

|Jun 13, 2025
Incidence and Predictors of Urethral Stricture Following Transurethral Resection of the Prostate and Open Simple Prostatectomy: A 21-Year Retrospective Cohort Study.

Dor Golomb, Meitar Atias, Hanan Goldberg

|Apr 25, 2025
Percentage of free to total PSA as a biomarker of survival in metastatic castration-resistant prostate cancer.

Andrew W Silagy, Dixon T S Woon, Louise Kostos

|Nov 20, 2024
Metastasis development in non-muscle-invasive bladder cancer.

Michael Leyderman, Thenappan Chandrasekar, Petros Grivas

|Jun 10, 2023
The Current Role of Lymph Node Dissection in Nonmetastatic Localized Renal Cell Carcinoma.

Megan Ngai, Thenappan Chandrasekar, Gennady Bratslavsky

|Nov 22, 2022
Role of Rucaparib in the Treatment of Prostate Cancer: Clinical Perspectives and Considerations.

Maximillian S Wu, Hanan Goldberg

Pageof 4

Frequent Collaborators

8 joint publications

Thenappan Chandrasekar

5 joint publications

Zachary Klaassen

4 joint publications

Christopher J D Wallis

4 joint publications

Gennady Bratslavsky